Length of Stay and Complications in High-risk Patients Receiving Fast-track Total Hip (THA) or Knee- Alloplasty (TKA)

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Completed
CT.gov ID
NCT01515670
Collaborator
Hvidovre University Hospital (Other), Aarhus University Hospital (Other), Vejle Hospital (Other), Sydvestjysk Hospital (Other), Regional Hospital Holstebro (Other), Naestved Hospital (Other), Bispebjerg Hospital (Other), Central Jutland Regional Hospital (Other), Aalborg University Hospital (Other)
60,000
7
107
8571.4
80.1

Study Details

Study Description

Brief Summary

The purpose of the study is to determine the influence of preoperative co-morbidity in relation to increased length of stay and postoperative complications in patients receiving fast-track hip or knee replacement.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Preoperative risk assessment is well established and repeatedly demonstrated to be related to adverse postoperative outcomes regarding all organ functions. However, all evidence is based upon conventional care programs and none has been done on fast-track surgery, neither in total hip arthroplasty (THA) or total knee arthroplasty (TKA).

    The purpose of this study series is therefore to evaluate the importance of conventional risk factors in an optimised fast-track TKA and THA set-up. These studies will be performed in the Lundbeck Foundation Center for fast-track THA and TKA, based on an established database, but with additional detailed risk information to be included in studies of certain types co-morbidity.

    The Lundbeck Foundation Center Database prospectively registers patient characteristics and co-morbidity in all patients receiving hip and knee arthroplasty. This is done using a questionaire and with dedicated staff available to help in case of doubt regarding specific questions. Additional information is collected by scrutinizing the patients medical charts. Completeness of data has been shown to be about 95%.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    60000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Length of Stay and Complications in High-risk Patients Receiving Fast-track Total Hip (THA) or Knee- Alloplasty (TKA).
    Actual Study Start Date :
    Feb 1, 2010
    Actual Primary Completion Date :
    Jan 1, 2019
    Actual Study Completion Date :
    Jan 1, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    Fast-track THA/TKA

    Any patient receiving THA/TKA in the participating wards

    Outcome Measures

    Primary Outcome Measures

    1. Length of hospital stay and reasons for length of hospital stay >4days [At discharge]

      Number of nights spend in hospital after day of surgery, including transferral between departments. Any procedure followed by more than 4 days in hospital will have review of discharge papers to determine causes of the "prolonged" admission

    2. Surgically related readmissions [90 days after surgery]

      Evaluation of any potentially surgery related readmission 90 days after discharge. Readmissions defined as related are defined as: Revision due to prosthesis problems, deep venous thrombosis (DVT), pulmonary embolism (PE) (verified or disproved), stroke/transitory cerebral ischaemia (TCI), possible wound infection (return to operating theatre, treatment with antibiotics only, no treatment), fractures without known trauma, falls, knee manipulation, hip dislocation, cardiac problems (acute myocardial infarction (AMI), any type of arrhythmia), pneumonia, urinary retention (UR), abdominal complications (gastric ulcer, ileus) and sequelae (rehabilitation, opioid side-effects, pain, other conditions related to surgery). Readmissions due to chronic obstructive lung disease (COPD), syncope and urinary tract infection (UTI) ≤ 30 days of primary admission

    Secondary Outcome Measures

    1. Mortality 90 days after surgery [90 days after surgery]

      Evaluation of all deaths 90 days after surgery

    Other Outcome Measures

    1. Co-morbidity related readmissions [90 days after surgery]

      Depending on the type of co-morbidity investigated, special attention and analysis of readmissions found to be related to the specific type of co-morbidity will be done

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Standardized elective fast-track THA or TKA
    Exclusion Criteria:
    • Elective THA or TKA not in regular fast-track setup

    • not a Danish citizen

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Himmerland Hospital Farsø Judland Denmark 9640
    2 Holstebro Regionalhospital Holstebro Judland Denmark 7500
    3 Vejle Hospital Vejle Judland Denmark 7100
    4 Hvidovre Hospital Hvidovre Seeland Denmark 2650
    5 Bispebjerg University Hospital Copenhagen Denmark
    6 Gentofte University Hospital Gentofte Denmark
    7 Næstved Hospital Næstved Denmark

    Sponsors and Collaborators

    • Rigshospitalet, Denmark
    • Hvidovre University Hospital
    • Aarhus University Hospital
    • Vejle Hospital
    • Sydvestjysk Hospital
    • Regional Hospital Holstebro
    • Naestved Hospital
    • Bispebjerg Hospital
    • Central Jutland Regional Hospital
    • Aalborg University Hospital

    Investigators

    • Principal Investigator: Christoffer C Joergensen, MD, Rigshospitalet, Denmark

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Christoffer Joergensen, Research-fellow, Rigshospitalet, Denmark
    ClinicalTrials.gov Identifier:
    NCT01515670
    Other Study ID Numbers:
    • RH30-0623
    First Posted:
    Jan 24, 2012
    Last Update Posted:
    Jun 22, 2021
    Last Verified:
    Jun 1, 2021
    Keywords provided by Christoffer Joergensen, Research-fellow, Rigshospitalet, Denmark

    Study Results

    No Results Posted as of Jun 22, 2021